Simplex Trading’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,300
Closed -$3K 11350
2022
Q2
$3K Sell
4,300
-36,400
-89% -$32.5K ﹤0.01% 9266
2022
Q1
$43K Sell
40,700
-4,700
-10% -$8.54K ﹤0.01% 7360
2021
Q4
$86K Buy
45,400
+17,300
+62% +$41.4K ﹤0.01% 6491
2021
Q3
$112K Hold
28,100
﹤0.01% 6462
2021
Q2
$109K Buy
28,100
+27,487
+4,484% +$114K ﹤0.01% 6613
2021
Q1
$310K Buy
613
+361
+143% +$1.87K ﹤0.01% 4107
2020
Q4
$103K Sell
252
-53
-17% -$260 ﹤0.01% 5423
2020
Q3
$148K Sell
305
-8
-3% -$44 ﹤0.01% 4476
2020
Q2
$173K Sell
313
-31
-9% -$142 ﹤0.01% 4154
2020
Q1
$112K Buy
344
+304
+760% +$1.6K ﹤0.01% 4255
2019
Q4
$18K Sell
40
-40
-50% -$127 ﹤0.01% 6045
2019
Q3
$33K Buy
80
+13
+19% +$47 ﹤0.01% 5415
2019
Q2
$25K Buy
+67
New +$275 ﹤0.01% 5453
2018
Q4
Sell
-2
Closed -$1K 8093
2018
Q3
$1K Sell
2
-8
-80% -$35 ﹤0.01% 7255
2018
Q2
$3K Sell
10
-4
-29% -$19 ﹤0.01% 6974
2018
Q1
$1K Buy
+14
New +$59 ﹤0.01% 5881
2017
Q4
Sell
-69
Closed -$1K 6931
2017
Q3
$1K Hold
69
﹤0.01% 5640
2017
Q2
$6K Buy
+69
New +$388 ﹤0.01% 4493
2016
Q4
Sell
-29
Closed -$6K 6752
2016
Q3
$6K Buy
+29
New +$391 ﹤0.01% 4172

Simplex Trading's AGTC Position: Q4 2022 in Review

Simplex Trading sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 20,259 shares — an estimated $5K sold.

Simplex Trading first reported a position in AGTC in Q1 2017 and held it in 10 quarters. The position peaked at $96K in Q3 2020. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • Simplex Trading reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 20,259 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $5K.
  • Simplex Trading first reported a position in Applied Genetic Technologies Corporation in Q1 2017 and held it in 10 quarters.
  • Simplex Trading's Applied Genetic Technologies Corporation position peaked at $96K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.